Rise In Respiratory Infections Driving The Market Growth Driver: A Major Catalyst in the Evolution of the Seasonal Influenza Market in 2025

What industry-specific factors are fueling the growth of the seasonal influenza market?
The growing prevalence of respiratory infections is expected to propel the growth of the seasonal influenza market in the future. Respiratory infections are illnesses caused by viruses or bacteria that affect the respiratory system, including the sinuses, throat, airways, or lungs. The rising prevalence of respiratory infections is driven by factors such as air pollution, changing climates, weakened immune responses, and the ease of viral transmission in crowded or poorly ventilated spaces. Seasonal influenza treatment helps prevent or reduce the severity of respiratory infections by addressing the influenza virus and managing symptoms that can lead to secondary infections. For example, in October 2024, the UK Health Security Agency, a U.K.-based government body, reported that tuberculosis (TB) cases in England had risen by 10.7% year-over-year in 2023, increasing from 4,380 cases in 2022 to 4,850 cases. Therefore, the rise in respiratory infections is expected to drive the growth of the seasonal influenza market.

Get Your Seasonal Influenza Market Report Here:
https://www.thebusinessresearchcompany.com/report/seasonal-influenza-global-market-report

What Is the projected market size and growth rate for the seasonal influenza market?
The seasonal influenza market has grown rapidly, increasing from $8.41 billion in 2024 to $9.88 billion in 2025 at a CAGR of 17.4%. This growth is driven by the rising prevalence of influenza, an aging population, a higher incidence of infectious and chronic diseases, an increasing burden of influenza-related illnesses, and a surge in respiratory infections.

The seasonal influenza market is expected to see rapid growth, reaching $18.55 billion by 2029 at a CAGR of 17.1%. The forecasted expansion is attributed to the increasing demand for oral drug solutions, expanding research and development activities, growing vaccination rates, improvements in healthcare infrastructure, and a rising need for retail pharmacy solutions. Major trends include advancements in treatment methods, technological innovations, progress in vaccine development, expansion of mRNA-based technology, and the adoption of digital health solutions for monitoring and diagnosis.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21285&type=smp

What new trends are reshaping the seasonal influenza market and its opportunities?
Major companies in the seasonal influenza market are developing combination vaccines to improve immunity by targeting multiple strains of the flu virus and reducing the need for frequent vaccinations. Combination vaccines protect against several diseases or strains with one injection, streamlining the immunization process. For instance, in October 2023, Moderna announced positive Phase 1/2 trial results for mRNA-1083, an investigational combination vaccine targeting both influenza and COVID-19. This vaccine aims to enhance compliance and simplify administration, offering an integrated solution to protect against multiple infections.

What major market segments define the scope and growth of the seasonal influenza market?
The seasonal influenza market covered in this report is segmented -

1) By Type: Influenza A Virus, Influenza B Virus, Influenza C Virus, Influenza D Virus
2) By Route Of Administration: Parenteral, Oral, Other Route Of Administrations
3) By Distribution Channel: Hospital, Government and institutional supply, Pharmacy, Online
4) By Treatment: Antiviral, Neuraminidase Inhibitors, Vaccination, Other Treatments

Subsegments:
1) By Influenza A Virus: Subtype H1N1, Subtype H3N2, Other Subtypes
2) By Influenza B Virus: Lineage Victoria, Lineage Yamagata
3) By Influenza C Virus: Seasonal C Virus, Non-seasonal C Virus
4) By Influenza D Virus: Animal-associated Influenza D

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21285

Which region dominates the seasonal influenza market?
North America was the largest region in the seasonal influenza market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the seasonal influenza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the seasonal influenza industry growth?
Major companies operating in the seasonal influenza market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Sanofi S.A., AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc, Merck KGaA, Moderna Inc., Boehringer Ingelheim International GmbH, Sinovac Biotech Ltd., Daiichi Sankyo Company Limited, CSL Limited, Genentech Inc., Shionogi & Co. Ltd., Emergent BioSolutions Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Bharat Biotech International Limited, Vaxart Inc., Inovio Pharmaceuticals Inc., SK bioscience Co. Ltd., Mitsubishi Tanabe Pharma Corporation, FluGen Inc., Altimmune Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21285&type=smp

What Is Covered In The Seasonal Influenza Global Market Report?

•Market Size Forecast: Examine the seasonal influenza market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the seasonal influenza market for a structured understanding.
•Key Players Overview: Analyze major players in the seasonal influenza market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the seasonal influenza market.
•Segment Contributions: Evaluate how different segments drive overall growth in the seasonal influenza market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the seasonal influenza market.
•Industry Challenges: Identify potential risks and obstacles affecting the seasonal influenza market.
•Competitive Landscape: Review strategic developments in the seasonal influenza market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.